Advertisement
U.S. Markets closed

ImpediMed Limited (IPD.AX)

ASX - ASX Delayed Price. Currency in AUD
0.05700.0000 (0.00%)
At close: 04:10PM AEDT
Currency in AUD

Valuation Measures4

Market Cap (intraday) 115.32M
Enterprise Value 91.83M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)11.46
Price/Book (mrq)2.83
Enterprise Value/Revenue 9.13
Enterprise Value/EBITDA -9.34

Trading Information

Stock Price History

Beta (5Y Monthly) 2.86
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.1600
52 Week Low 30.0420
50-Day Moving Average 30.0551
200-Day Moving Average 30.0760

Share Statistics

Avg Vol (3 month) 32.07M
Avg Vol (10 day) 31.75M
Shares Outstanding 52.02B
Implied Shares Outstanding 6N/A
Float 81.79B
% Held by Insiders 19.08%
% Held by Institutions 116.29%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2102:100
Last Split Date 3Jun 01, 2009

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -191.78%
Operating Margin (ttm)-200.92%

Management Effectiveness

Return on Assets (ttm)-25.96%
Return on Equity (ttm)-38.95%

Income Statement

Revenue (ttm)10.32M
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-2.70%
Gross Profit (ttm)N/A
EBITDA -23.46M
Net Income Avi to Common (ttm)-19.79M
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)24.63M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)1.14M
Total Debt/Equity (mrq)2.81
Current Ratio (mrq)6.33
Book Value Per Share (mrq)0.02

Cash Flow Statement

Operating Cash Flow (ttm)-17.79M
Levered Free Cash Flow (ttm)-16.44M